New research has revealed a potentially important role ginger supplements can play in controlling inflammation for people living with autoimmune diseases. The research focused on studying the impact of ginger supplementation on a type of white blood cell called the neutrophil. The study was especially interested in neutrophil extracellular trap (NET) formation, also known as NETosis, and what it may mean for controlling inflammation. The study found ginger consumption by healthy individuals makes their neutrophils more resistant to NETosis. This is important because NETs are microscopic spider web-like structures that propel inflammation and clotting, which contribute to many autoimmune diseases, including lupus, antiphospholipid syndrome and rheumatoid arthritis.

New research found that nearly 1 in 20 adults in the U.S. experience the co-occurrence of chronic pain and anxiety or depression, resulting in functional limitations in daily life.

Is it possible that a single biomarker can detect all types of diseases related to dopamine deficiency in the brain? Yes, that's what a research group is discovering. 'We have observed that an enzyme in cerebrospinal fluid and in blood is a useful marker for identifying all types of Parkinson's-related diseases with high accuracy,' says the study leader.

A telecare program that improves outcomes for patients with dementia and lightens the load for unpaid caregivers also has the surprising bonus of cutting Medicare costs, according to new research.

A new study challenges a common belief in what triggers Parkinson's disease. Degeneration of dopaminergic neurons is widely accepted as the first event that leads to Parkinson's. But the new study suggests that a dysfunction in the neuron's synapses leads to deficits in dopamine and precedes the neurodegeneration. The findings open a new avenue for therapies in which drugs target neuron synapses before neurons degenerate.

Western University has developed a ground-breaking method for predicting which intensive care unit (ICU) patients will survive a severe brain injury by combining functional magnetic resonance imaging (fMRI) with state-of-the art machine learning techniques.

Finding the right medication regimen to treat Parkinson's disease (PD) is a complex healthcare challenge. Wearable health trackers provide physicians with a detailed window into patients' symptoms, but translating this complex data into useful treatment insights can be difficult. New research accomplishes just that. Researchers found that combining wearable health tracker data with state-of-the-art algorithms results in promising treatment strategies that could improve PD patients' outcomes.

Researchers have identified a new pathological mechanism for a familial type of Parkinson's disease caused by a mutation in the CHCHD2 gene. Mutant CHCHD2 protein is mislocalized in cells and leads to alpha-synuclein protein aggregates via interactions with another protein, known as Csnk1e/d. These findings indicate that Csnk1e/d inhibition may slow or halt Parkinson's disease development in patients with CHCHD2 mutations, providing new hope for affected families.

An analysis of data from a long-running study of more than 11,000 adults from four diverse communities in the United States has found that adults who had high blood pressure while both seated upright and lying supine (flat on their backs) had a higher risk of heart disease, stroke, heart failure or premature death compared to adults without high blood pressure while upright and supine.

A new artificial intelligence tool can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. While expert neurologists performed slightly better than the AI model, the AI model outperformed the primary care physicians with UPDRS certification.

Researchers have discovered a new avenue of cell death in Alzheimer's disease and vascular dementia. The study reveals for the first time that a form of cell death known as ferroptosis -- caused by a buildup of iron in cells -- destroys microglia cells in cases of Alzheimer's and vascular dementia.

People who have had a stroke called an intracerebral hemorrhage who take cholesterol-lowering drugs called statins may have a lower risk of having another stroke, especially ischemic stroke, compared to people who also had an intracerebral hemorrhage but were not taking statins.

Researchers have developed a new way of identifying patients at risk of an irregular heartbeat, known as 'atrial fibrillation'. While not life threatening, the condition increases people's risk of having a transient ischaemic attack (TIA) or stroke by up to five times. A new study reveals four specific factors that can predict which patients will have atrial fibrillation. These include older age, higher diastolic blood pressure and problems with both the coordination and function of the upper left chamber of the heart. The team went on to create an easy tool for doctors to use in practice to identify those at high risk. And they hope that this will help diagnose and treat more patients, reducing their risk of future strokes.

Middle-aged adults with three or more unhealthy traits including slightly high waist circumference, blood pressure, cholesterol and glucose have heart attacks and strokes two years earlier than their peers, according to new research.

Patients living with one of the UK's most common heart rhythm conditions are 50% less likely to die from a heart attack or stroke than they were at the start of the millennium, analysis of 70,000 newly diagnosed AF patients' health records has shown.